Defining epitopes: It's not as easy as it seems View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-10

AUTHORS

Neil S. Greenspan, Enrico Di Cera

ABSTRACT

N/A

PAGES

936-937

References to SciGraph publications

Journal

TITLE

Nature Biotechnology

ISSUE

10

VOLUME

17

Related Patents

  • Binds To A Denatured Collagens But Not To Native Triple Helical Forms Of The Collagen; Antitumor Agents, Antimetastasis Agents; Monoclonal Antibodies; Drug Screening For Denatured Collagen Antagonists
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Targeted Cryptosporidium Biocides
  • Constructs And Libraries Comprising Antibody Surrogate Light Chain Sequences
  • Palivizumab Formulation Comprising In Aqueous Carrier At Least 40 Mg/Ml Of Palivizumab, Or An Antigen-Binding Fragment Thereof And Histidine, Wherein Formulation Is Free Of Surfactants And Inorganic Salts; For Preventing Or Treating Symptoms Associated With A Respiratory Syncytial Virus Infection
  • Anti-Glypican-3 Antibody
  • Compositions, Methods And Uses For Alpha-1 Antitrypsin Fusion Molecules
  • Surface Exposed Haemophilus Influenzae Protein (Protein E; Pe)
  • Specific Binding Proteins And Uses Thereof
  • Anti-Mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
  • Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen
  • Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Anti-C3d Antibody Conjugates And Methods Of Detecting Complement Activation
  • Compositions And Methods For Treating Fungal And Bacterial Pathogens
  • Clostridium Difficile Antibodies
  • Immunoglobulin Fc Libraries
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Recombinant Microorganisms And Uses Thereof
  • Notch1 Binding Agents And Methods Of Use Thereof
  • Streptococcal Peptide For Use In Prevention And Treatment Of Microorganismal Infection; Bactericides; Microbiocides
  • Immunogenic Proteins Of Leptospira
  • Early Diagnosis Of Infections
  • Humanized Collagen Antibodies And Related Methods
  • Heterologous Expression Of Neisserial Proteins
  • Mdr E. Coli Specific Antibody
  • Immunogens, Compositions And Uses Thereof, Method For Preparing Same
  • Induction Of Tumor Immunity By Variants Of Folate Binding Protein
  • Binding Moieties For Biofilm Remediation
  • Glycosylated Specificity Exchangers
  • Immunogenic Proteins Of Leptospira
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Modified Hiv-1 Envelope Proteins
  • Bacterial Vaccine Components And Uses Thereof
  • Therapeutic Agent For Hematopoietic Tumors
  • Method For Eliciting An Immune Response To Human Telomerase Reverse Transcriptase
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Compositions And Methods For Immunodominant Antigens Of Mycobacterium Tuberculosis
  • Fusion Proteins Of Mycobacterium Tuberculosis
  • Pd-1 Specific Antibodies And Uses Thereof
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Combining Radioimmunotherapy And Antibody-Drug Conjugates For Improved Cancer Therapy
  • Anti-Egfr Antibodies And Antibody Drug Conjugates
  • Fusion Proteins Of Mycobacterium Tuberculosis
  • Modified Biotin-Binding Protein
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Recombinant Outer Membrane Proteins From Brachyspira Hyodysenteriae And Uses Thereof
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Inhibit Tumor Growth, Or Metastasis By Modifying Protein-Protein Interactions Involving Certain Amino Acid Sequences Within Matrix Metalloproteinase 9 (Mmp-9)
  • Internalizing Human Monoclonal Antibodies Targeting Prostate And Other Cancer Cells
  • Gna1870-Based Vesicle Vaccines For Broad Spectrum Protection Against Diseases Caused By Neisseria Meningitidis
  • Regulated Expression Of Antigen And/Or Regulated Attentuation To Enhance Vaccine Immunogenicity And/Or Safety
  • Grass Peptides For Vaccine
  • Activin-Actrii Antagonists And Uses For Treating Anemia
  • Vectors For Molecule Delivery To Cd11b Expressing Cells
  • Wnt Antagonist And Methods Of Treatment And Screening
  • Method Of Diagnosis Of Infection By Mycobacteria And Reagents Therefor
  • Complex Of Antigen, Antibody Or Ligand, Receptor; Therapy Or Prevent Human Disease
  • Methods For Detecting Antibody That Specifically Bind A Siderophore Receptor Polypeptide
  • Hmgb1 And Anti-Hmgb1 Antibodies For The Prognostic Of Neurological Disorders
  • Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens
  • Pharmaceutical Compositions And Methods To Vaccinate Against Disseminated Candidiasis And Other Infectious Agents
  • Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells
  • Monoclonal Abtibody Specific To Prostate Cell-Surface Antigen Associated With Androgen-Dependent And Androgen-Independent Prostate Tumors For Use In Prevention, Diagnosis And Treatment Of Cell Proliferative Disorders; Immunodiagnostics; Immunotherapy
  • Recombinant Bacterium Capable Of Eliciting An Immune Response Against Streptococcus Pneumoniae
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Activin-Actriia Antagonists For Treating A Follicle-Stimulating Horomone-Secreting Pituitary Tumor
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • S. Epidermidis Antigens
  • Pharmaceutical Composition Containing A Stabilised Mrna Optimised For Translation In Its Coding Regions
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Compositions And Methods For Detection Of Antibodies Specific For Anaplasma Phagocytophilum (Aph) And Anaplasma Platys (Apl)
  • Anti-Ang2 Antibody
  • The Antibodies Bind To Whole Bacteria And Enhance Phagocytosis And Killing Of The Bacteria In Vitro And Enhance Protection From Lethal Infection In Vivo
  • Humanized And Affinity Matured Antibodies To Fcrh5 And Methods Of Use
  • Method For Treating Helicobacter Pylori Infections
  • Metastatic Colorectal Cancer Vaccine
  • Basb019 Proteins And Genes From Moraxella Catarrhalis, Antigens, Antibodies, And Uses
  • Methods Of Treating Cancer By Administering A Soluble Receptor Comprising A Human Fc Domain And The Fri Domain From Human Frizzled Receptor
  • Immunogenic Compositions For Streptococcus Pyogenes
  • Immunogenic Proteins And Compositions
  • Compositions And Methods Relating To A Mutant Clostridium Difficile Toxin
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Method For Preventing Or Treating Influenza Virus Infection Using Pharmaceutical Composition Comprising Immunoglobulin Fc-Fused Interleukin-7 Fusion Protein
  • Immunoglobulin G-Degrading Enzyme For Use As Tool In Diagnosis, Prevention And Treatment Of Streptococcal Infection
  • Multivalent Vaccine Protection From Staphylococcus Aureus Infection
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Antibodies To Insulin-Like Growth Factor I Receptor
  • Computational Analysis Of Biological Data Using Manifold And A Hyperplane
  • Compositions And Methods For The Removal Of Biofilms
  • Dirofilaria Non-Collagenous Protein For Use In Developing Vaccine For Prevention And Treatment Of Nematode Infection; Veterinary Medicine
  • Anti-Arthropod Vector Vaccines, Methods Of Selecting And Uses Thereof
  • Humanized And Affinity Matured Antibodies To Fcrh5 And Methods Of Use
  • Neutralizing Anti-Influenza A Antibodies And Uses Thereof
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Anti-Glypican-3 Antibody
  • Compositions, Methods And Uses For Alpha-1 Antitrypsin Fusion Molecules
  • Mdr E. Coli Specific Antibody
  • Heterologous Expression Of Neisserial Proteins
  • High Throughput Cell-Based Hpv Immunoassays For Diagnosis And Screening Of Hpv-Associated Cancers
  • Binding Moieties For Biofilm Remediation
  • Induction Of Tumor Immunity By Variants Of Folate Binding Protein
  • Administering Recombinant Listeria Strain Comprising Integrated Nucleic Acid Molecule Having Two Open Reading Frames Expressing Heterologous Antigen And Metabolic Enzyme
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Improved Modular Antigen Transportation Molecules And Uses Therof
  • Her-2 Binding Antagonists
  • Antibiotic Resistance Free Vaccines And Methods For Constructing And Using Same
  • Immunogenic Proteins Of Leptospira
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Immunogens, Compositions And Uses Thereof, Method For Preparing Same
  • Modified Hiv-1 Envelope Proteins
  • Bacterial Vaccine Components And Uses Thereof
  • Glycosylated Specificity Exchangers
  • Compounds, Compositions And Methods Of Treating Cancer And Fibrotic Diseases
  • Type Iii Secretion System Targeting Molecules
  • Methods For Increasing Thermogenic Adipocytes
  • Ovarian Cancer Cell And Myeloma Cell Surface Glycoproteins, Antibodies Thereto, And Uses Thereof
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Detection Human Integrin Associated Protein
  • Isolated Polynucleotide That Encodes An Actriia-Fc Fusion Polypeptide
  • Vaccines And Compositions Against Streptococcus Pneumoniae
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Attenuated Pestivirus
  • Antibodies Against Staphylococcus Aureus And Uses Therof
  • Engineered Immunoglobulin Fc Polypeptides Displaying Improved Complement Activation
  • Human Genes Relating To Respiratory Diseases And Obesity
  • Modified Biotin-Binding Protein
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Hmgb1 And Anti-Hmgb1 Antibodies For The Prognostic Of Neurological Disorders
  • Methods For Detecting Antibody That Specifically Bind A Siderophore Receptor Polypeptide
  • Monoclonal Abtibody Specific To Prostate Cell-Surface Antigen Associated With Androgen-Dependent And Androgen-Independent Prostate Tumors For Use In Prevention, Diagnosis And Treatment Of Cell Proliferative Disorders; Immunodiagnostics; Immunotherapy
  • Pd-1 Specific Antibodies And Uses Thereof
  • Recombinant Microorganisms And Uses Thereof
  • Method For Preventing Or Treating Influenza Virus Infection Using Pharmaceutical Composition Comprising Immunoglobulin Fc-Fused Interleukin-7 Fusion Protein
  • Immunoglobulin G-Degrading Enzyme For Use As Tool In Diagnosis, Prevention And Treatment Of Streptococcal Infection
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Compositions And Methods For Immunodominant Antigens Of Mycobacterium Tuberculosis
  • Recombinant Bacterium Capable Of Eliciting An Immune Response Against Streptococcus Pneumoniae
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Activin-Actriia Antagonists For Treating A Follicle-Stimulating Horomone-Secreting Pituitary Tumor
  • Anti-C3d Antibody Conjugates And Methods Of Detecting Complement Activation
  • Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen
  • Immunogenic Proteins Of Leptospira
  • Notch1 Binding Agents And Methods Of Use Thereof
  • Streptococcal Peptide For Use In Prevention And Treatment Of Microorganismal Infection; Bactericides; Microbiocides
  • Metastatic Colorectal Cancer Vaccine
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Therapeutic Agent For Hematopoietic Tumors
  • Method For Eliciting An Immune Response To Human Telomerase Reverse Transcriptase
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Recombinant Outer Membrane Proteins From Brachyspira Hyodysenteriae And Uses Thereof
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Early Diagnosis Of Infections
  • Humanized Collagen Antibodies And Related Methods
  • Methods Of Treating Cancer By Administering A Soluble Receptor Comprising A Human Fc Domain And The Fri Domain From Human Frizzled Receptor
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Immunogenic Compositions For Streptococcus Pyogenes
  • Basb019 Proteins And Genes From Moraxella Catarrhalis, Antigens, Antibodies, And Uses
  • Immunogenic Proteins And Compositions
  • Compositions And Methods Relating To A Mutant Clostridium Difficile Toxin
  • Fusion Proteins Of Mycobacterium Tuberculosis
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Compositions And Methods For Treating Fungal And Bacterial Pathogens
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Immunoglobulin Fc Libraries
  • The Antibodies Bind To Whole Bacteria And Enhance Phagocytosis And Killing Of The Bacteria In Vitro And Enhance Protection From Lethal Infection In Vivo
  • Method Of Diagnosis Of Infection By Mycobacteria And Reagents Therefor
  • Wnt Antagonist And Methods Of Treatment And Screening
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Internalizing Human Monoclonal Antibodies Targeting Prostate And Other Cancer Cells
  • Inhibit Tumor Growth, Or Metastasis By Modifying Protein-Protein Interactions Involving Certain Amino Acid Sequences Within Matrix Metalloproteinase 9 (Mmp-9)
  • Activin-Actrii Antagonists And Uses For Treating Anemia
  • Vectors For Molecule Delivery To Cd11b Expressing Cells
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • S. Epidermidis Antigens
  • Humanized And Affinity Matured Antibodies To Fcrh5 And Methods Of Use
  • Compositions And Methods For Detection Of Antibodies Specific For Anaplasma Phagocytophilum (Aph) And Anaplasma Platys (Apl)
  • Multivalent Vaccine Protection From Staphylococcus Aureus Infection
  • Regulated Expression Of Antigen And/Or Regulated Attentuation To Enhance Vaccine Immunogenicity And/Or Safety
  • Method For Treating Helicobacter Pylori Infections
  • Gna1870-Based Vesicle Vaccines For Broad Spectrum Protection Against Diseases Caused By Neisseria Meningitidis
  • Complex Of Antigen, Antibody Or Ligand, Receptor; Therapy Or Prevent Human Disease
  • Combining Radioimmunotherapy And Antibody-Drug Conjugates For Improved Cancer Therapy
  • Pharmaceutical Composition Containing A Stabilised Mrna Optimised For Translation In Its Coding Regions
  • Anti-Ang2 Antibody
  • Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens
  • Pharmaceutical Compositions And Methods To Vaccinate Against Disseminated Candidiasis And Other Infectious Agents
  • Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells
  • Anti-Egfr Antibodies And Antibody Drug Conjugates
  • Fusion Proteins Of Mycobacterium Tuberculosis
  • Antagonists Of Activin-Actriia And Uses For Increasing Red Blood Cell Levels
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Grass Peptides For Vaccine
  • High Throughput Cell-Based Hpv Immunoassays For Diagnosis And Screening Of Hpv-Associated Cancers
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Methods Of Stimulating Immunity Employing Dengue Viral Antigens
  • Bispecific Antigen-Binding Molecules That Bind A Staphylococcus Target Antigen And A Complement Component And Uses Thereof
  • Related To Testes-Specific, Vespid And Pathogenic Proteins (Rtvp); Metastatic Prostatic Neoplasia
  • Compounds And Methods For Immunotherapy And Diagnosis Of Tuberculosis
  • Proteins Used For The Diagnosis Of Lyme Borreliosis
  • Gas57 Mutant Antigens And Gas57 Antibodies
  • Vectors For Molecule Delivery To Cd11b Expressing Cells
  • Cytotoxicity-Inducing Therapeutic Agent
  • Anti-Cd27 And Anti-Pd-L1 Antibodies And Bispecific Constructs
  • Anti-Egfr Antibodies And Antibody Drug Conjugates
  • Vaccines Against Antigens Involved In Therapy Resistance And Methods Of Using Same
  • Nucleic Acids And Proteins From Streptococcus Groups A And B
  • Methods For Constructing Antibiotic Resistance Free Vaccines
  • Protein-Active Agent Conjugates And Method For Preparing The Same
  • Binding Moieties For Biofilm Remediation
  • Nucleic Acids And Proteins From Streptococcus Groups A And B
  • Gene Gms 01
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Anti-Mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
  • Antigens And Vaccines Against Piscirickettsia Salmonis
  • Compositions And Methods Of Enhancing Immune Responses To Eimeria Or Limiting Eimeria Infection
  • Methods And Compositions Based On Shiga Toxin Type 1 Protein
  • Bio-Functionalized Stimulus-Responsive Dissolvable Peg-Hydrogels
  • Methods Of Stimulating Liver Regeneration
  • Regulated Expression Of Antigen And/Or Regulated Attentuation To Enhance Vaccine Immunogenicity And/Or Safety
  • Enterococcus Faecalis And/Or Enterococcus Faecium Antigen
  • Methods For Improving Anti-Cd37 Immunoconjugate Therapy
  • Nucleic Acids Encoding Inactive Variants Of Human Telomerase
  • Canine Babesiosis Vaccine Antigen
  • Pathogenic Mycobacteria-Derived Mannose-Capped Lipoarabinomannan Antigen Binding Proteins
  • Method Of Treating Cancer By Inhibition Of P95her-2 Production
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Polypeptides Include Somatostatin-14 Fused To A Substantially Inactivated Chloramphenicol Acetyl Transferase Protein Via A Functionally Optimized Linker; Chimeric Polypeptides Provide Highly Effective And Low Cost Materials For Use In The Animal Husbandry Field; Increasing Milk Production
  • Immune Suppressor And Its Use
  • Composition Of Anti-Endo180 Antibodies And Methods Of Use For The Treatment Of Cancer And Fibrotic Diseases
  • Targeted Cryptosporidium Biocides
  • Humanized Anti-Prostate Stem Cell Antigen Monoclonal Antibody
  • Anti-P53 Single-Chain Antibody Fragments And Their Uses
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Gas57 Mutant Antigens And Gas57 Antibodies
  • Peptides And Antibodies For The Removal Of Biofilms
  • Methods For Increasing Thermogenic Adipocytes
  • Serologic Correlates Of Protection Against Bacillis Anthracis Infection
  • Human Antibodies That Bind Mesothelin, And Uses Thereof
  • Peptide Sequences And Compositions
  • Treatment Of Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Anemias And Disease States Involving Intravascular And Extravascular Hemolysis
  • Her-2 Binding Antagonists
  • Specific Binding Proteins And Uses Thereof
  • Use Of Anti-Egfr Antibodies In Treatment Of Egfr Mutant Mediated Disease
  • Compounds And Methods For Immunotherapy And Diagnosis Of Tuberculosis
  • Activin-Actriia Antagonists And Uses For Treating Multiple Myeloma
  • Attenuated Pestiviruses
  • Mva-Gh/Gl-Pc Vaccine Derived Antibodies Neutralizing Human Cytomegalovirus Infectivtiy And Methods Thereof
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Methods And Compositions For Detection Of Ehrlichia Chaffeensis (P120)
  • Nucleic Acids Encoding Gas57 Mutant Antigens
  • Compounds And Methods For Treatment And Diagnosis Of Chlamydial Infection
  • Anti Hla-G Specific Antibodies
  • Methods Of Inducing An Immune Response
  • Method Of Treating Cancer Using Antibodies To A Non-Ligand Binding Region Of Notch1
  • Compositions Comprising Bacterial Strains
  • Antibodies Exhibit Increased Antibody-Dependent Cellular Cytotoxicity Activity; Humanizing, Chimera
  • Antibody Which Binds Fetal Thymocytes, Inhibitits Cell Proliferation And Does Not Bind Adult Thymocytes; For Use In Treatment And Prevention Of Cell Proliferative Disorders; Immunotherapy
  • Compositions And Methods Of Enhancing Immune Responses To Enteric Pathogens
  • Vaccines And Compositions Against Streptococcus Pneumoniae
  • Specific Binding Molecules For Scintigraphy, Conjugates Containing Them And Therapeutic Method For Treatment Of Angiogenesis
  • Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
  • Immunogens And Methods For Discovery And Screening Thereof
  • Peptide Analogs Capable Of Enhancing Stimulation Of A Glioma-Specific Ctl Response
  • Combining Radioimmunotherapy And Antibody-Drug Conjugates For Improved Cancer Therapy
  • Structural Isomers Of Sc(Fv)2
  • Activin-Actriia Antagonists And Uses For Decreasing Or Inhibiting Fsh Secretion
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Staphylococcus Aureus Proteins And Nucleic Acids
  • Neisseria Meningitidis Antigens And Compositions
  • Internalizing Human Monoclonal Antibodies Targeting Prostate Cancer Cells In Situ
  • Mdr E. Coli Specific Antibody
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Heterologous Expression Of Neisserial Proteins
  • Compositions Of, And Methods For, Alpha-1 Antitrypsin Fc Fusion Molecules
  • Gna1870-Based Vesicle Vaccines For Broad Spectrum Protection Against Diseases Caused By Neisseria Meningitidis
  • Clostridium Difficile Antibodies
  • Detecting Binding To Epitope; Use In Immunoassays, Imaging, Diagnosis And Treatment Of Cancer
  • Humanized Collagen Antibodies And Related Methods
  • Proteins Which Comprise Stretches Of Amino Acid Sequence That Are Shared Across The Majority Of Neisseria, Particularly N. Meningitidis And N. Gonorrhoeae
  • Immunogenic Proteins Of Leptospira
  • Composition Comprising Bacterial Strains
  • Combining Radioimmunotherapy And Antibody-Drug Conjugates For Improved Cancer Therapy
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Basb205 Polypeptides And Polynucleotides From Haemophilus Influenzae
  • Engineered Immunoglobulin Fc Polypeptides Displaying Improved Complement Activation
  • Single-Chain Chimeric Polypeptides And Uses Thereof
  • Infectious Bovine Viral Diarrhea Virus
  • Group B Streptococcus Antigens
  • Compositions Comprising Bacterial Strains
  • Localization And Characterization Of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes And Methods For Their Use
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Gene Gms 01
  • Antigens And Vaccines Against Piscirickettsia Salmonis
  • Compositions And Methods Of Enhancing Immune Responses To Eimeria Or Limiting Eimeria Infection
  • Methods And Compositions Based On Shiga Toxin Type 1 Protein
  • Bio-Functionalized Stimulus-Responsive Dissolvable Peg-Hydrogels
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Related To Testes-Specific, Vespid And Pathogenic Proteins (Rtvp); Metastatic Prostatic Neoplasia
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Nucleic Acids And Proteins From Streptococcus Groups A & B
  • Antibodies And Assays For Detection Of Cd37
  • Recombinant Mva Virus And The Use Thereof
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Method Of Treating Cancer By Inhibition Of P95her-2 Production
  • Binding Moieties For Biofilm Remediation
  • Infectious Bovine Viral Diarrhea Virus
  • Detection Of Early Stages And Late Stages Hpv Infection
  • Activin-Actriia Antagonists And Uses For Treating Or Preventing Breast Cancer
  • Multivalent Pneumococcal Vaccines
  • Compositions Of, And Methods For, Alpha-1 Antitrypsin Fc Fusion Molecules
  • Gna1870-Based Vesicle Vaccines For Broad Spectrum Protection Against Diseases Caused By Neisseria Meningitidis
  • Three-Component-Multistage Malaria Vaccine
  • Basb205 Polypeptides And Polynucleotides From Haemophilus Influenzae
  • Engineered Immunoglobulin Fc Polypeptides Displaying Improved Complement Activation
  • Single-Chain Chimeric Polypeptides And Uses Thereof
  • Variants Derived From Actriib And Uses Therefor
  • Detection Of Early Stages And Late Stages Hpv Infection
  • Heterologous Expression Of Neisserial Proteins
  • Combining Radioimmunotherapy And Antibody-Drug Conjugates For Improved Cancer Therapy
  • Group B Streptococcus Antigens
  • Compositions Comprising Bacterial Strains
  • Localization And Characterization Of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes And Methods For Their Use
  • Clostridium Difficile Antibodies
  • Proteins Which Comprise Stretches Of Amino Acid Sequence That Are Shared Across The Majority Of Neisseria, Particularly N. Meningitidis And N. Gonorrhoeae
  • Humanized Collagen Antibodies And Related Methods
  • Heterologous Expression Of Neisserial Proteins
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Antibodies Against Clostridium Difficile Toxins And Uses Thereof
  • Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Detecting Binding To Epitope; Use In Immunoassays, Imaging, Diagnosis And Treatment Of Cancer
  • High Potency Recombinant Antibodies And Method For Producing Them
  • Immunogenic Proteins Of Leptospira
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens
  • Anti-Mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Multi-Analyte Microarrays Using Tag-Specific Antibodies And Tag-Anchored Antibodies
  • Self-Regulating Device For Modulating Inflammation
  • Compositions Comprising Bacterial Strains
  • Compositions And Methods Of Enhancing Immune Responses To Eimeria Or Limiting Eimeria Infection
  • Antibody-Active Agent Conjugates And Methods Of Use
  • Human Antibodies Against Pseudomonas Aeruginosa Lps
  • Method Of Promoting Bone Growth By An Anti-Activin B Antibody
  • Compositions And Methods For Immunodominant Antigens Of Mycobacterium Tuberculosis
  • S. Epidermidis Antigens
  • Recombinant Antibodies And Immunoconjugates Targeted To Cd-22 Bearing Cells And Tumors
  • Chmeric Polypeptides
  • Adjuvant Combinations Of Liposomes And Mycobacterial Lipids For Immunization Compositions And Vaccines
  • Compositions, Methods And Therapies For Administering Antigen Peptide
  • Using Mg1(Mucin) Specific Immunoglobulins To Target Therapeutic Agents To Tumor Cells
  • Vaccines And Compositions Against Streptococcus Pneumoniae
  • Adjuvanted Rabies Vaccine With Improved Viscosity Profile
  • Immunogenic Proteins And Compositions
  • Human Antibodies That Bind Mesothelin, And Uses Thereof
  • Immunogenic Compositions For Streptococcus Pyogenes
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Bacterium Comprising A Regulated Rfah Nucleic Acid
  • Antibodies To Egf Receptor Epitope Peptides And Uses Thereof
  • Anti-Mesothelin Antibodies
  • Modified Surface Antigen
  • Monovalent, Bivalent And Trivalent Anti Human Respiratory Syncytial Virus (Hrsv) Nanobody Constructs For The Prevention And/Or Treatment Of Respiratory Tract Infections
  • Mva Expressing Modified Hiv Envelope, Gag, And Pol Genes
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Anti-Fcrh5 Antibodies
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Bacterium For Use As A Probiotic For Nutritional And Medical Applications
  • Activin-Actrii Antagonists And Uses For Treating Bone And Other Disorders
  • Cross-Species-Specific Psmaxcd3 Bispecific Single Chain Antibody
  • Human Antibodies That Bind Mesothelin, And Uses Thereof
  • Vaccines Against An Oncogenic Isoform Of Her2 (Erbb2) And Methods Of Using The Same
  • Humanized Antibodies Against Cd269 (Bcma)
  • Method For Producing An Actriib-Fc Fusion Polypeptide
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Methods Of Using Antibodies That Bind The Glutamate Ligand Binding Region Of Notch1
  • Induction Of Tumor Immunity By Variants Of Folate Binding Protein
  • Chimeric Recombinant Antigens Of Toxoplasma Gondii
  • An Antagonist Specifically Binds To A Denatured Collagens; Antitumor Agents, Antimetastasis Agents; Monoclonal Antibodies; Drug Screening For Denatured Collagen Antagonists
  • Chlamydial Antigens As Reagents For Diagnosis And Treatment Of Chlamydial Infection And Disease
  • Compositions Comprising Bacterial Strains
  • Streptococcus Pyogenes Antigens And Corresponding Dna Fragments
  • Methods For Screening Compounds For Increasing Thermogenic Adipocytes
  • Neutralizing Molecules To Viral Antigens
  • Bacterial Vaccine Components And Uses Thereof
  • Neutralizing Anti-Influenza Binding Molecules And Uses Thereof
  • Anti-Campylobacter Jejuni Antibodies And Uses Therefor
  • Streptococcus Suis Polypeptides And Polynucleotides Encoding Same And Their Use In Vaccinal And Diagnostic Applications
  • Methods And Compositions Based On Shiga Toxin Type 2 Protein
  • Mutant Forms Of Streptolysin O
  • Immunogenic Compositions And Diagnostic And Therapeutic Uses Thereof
  • Modified Surface Antigen
  • Polynucleotides Encoding Notch Receptor Antibodies
  • Isolated Nucleic Acid Encoding A Truncated Actriib Fusion Protein
  • Specified Complementary Determining Region (Crd) Amino Acid Sequences; Specific Binding Activity For A Cryptic Collagen Epitope; Angiogenesis Inhibition, Antimetastasis, And Tumor-Targeted Therapy Uses
  • Method Of Increasing Red Blood Cell Levels Or Treating Anemia In A Patient
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Notch1 Receptor Antibodies And Methods Of Treatment
  • Anti C-Met Antibodies
  • Streptococcus Pyogenes Antigens And Corresponding Dna Fragments
  • Antibodies Against F Glycoprotein Of Hendra And Nipah Viruses
  • Anti-Pcsk9 Antibodies
  • Respiratory Syncytial Virus Therapy; Sustained Release
  • Nucleic Acid Vector Comprising A Promoter And A Sequence Encoding A Polypeptide From The Endogenous Retrovirus Pcav
  • Immunogenic Compositions For Streptococcus Pyogenes
  • Anti-Plasmodium Parasite Antibodies
  • Subunit Immersion Vaccines For Fish
  • Materials And Methods Relating To Improved Vaccination Strategies
  • Glycosylated Specificity Exchangers
  • Compositions And Methods For The Removal Of Biofilms
  • Methods And Kits For Use In Preventing And Treating Vulvovaginal Candidiasis
  • Compositions Comprising Bacterial Strains
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Neutralizing Anti-Influenza B Antibodies And Uses Thereof
  • Methods And Compositions Based On Shiga Toxin Type 2 Protein
  • Streptococcus Pyogenes Antigens And Corresponding Dna Fragments
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Streptococcus Suis Polypeptides And Polynucleotides Encoding Same And Their Use In Vaccinal And Diagnostic Applications
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Modified Surface Antigen
  • Monovalent, Bivalent And Trivalent Anti Human Respiratory Syncytial Virus (Hrsv) Nanobody Constructs For The Prevention And/Or Treatment Of Respiratory Tract Infections
  • Mva Expressing Modified Hiv Envelope, Gag, And Pol Genes
  • Activin-Actrii Antagonists And Uses For Treating Bone And Other Disorders
  • Immunogenic Compositions For Streptococcus Pyogenes
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Bacterium Comprising A Regulated Rfah Nucleic Acid
  • Chimeric Recombinant Antigens Of Toxoplasma Gondii
  • Anti-Mesothelin Antibodies
  • Antibodies To Egf Receptor Epitope Peptides And Uses Thereof
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Humanized Antibodies Against Cd269 (Bcma)
  • Method For Producing An Actriib-Fc Fusion Polypeptide
  • Vaccines And Compositions Against Streptococcus Pneumoniae
  • Adjuvant Combinations Of Liposomes And Mycobacterial Lipids For Immunization Compositions And Vaccines
  • Chmeric Polypeptides
  • Methods Of Using Antibodies That Bind The Glutamate Ligand Binding Region Of Notch1
  • Induction Of Tumor Immunity By Variants Of Folate Binding Protein
  • Methods For Inhibiting Hematopoiesis With A Hedgehog Antagonist
  • Compositions And Methods For The Detection And Treatment Of Methylthioadenosine Phosphorylase Deficient Cancers
  • Hpv Types And Variants Associated With Cervical Cancer And The Uses Thereof
  • High Throughput Cell-Based Hpv Immunoassays For Diagnosis And Screening Of Hpv-Associated Cancers
  • Anti-Glypican-3 Antibody
  • Cross-Species-Specific Psmaxcd3 Bispecific Single Chain Antibody
  • Anti-Fcrh5 Antibodies
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Bacterium For Use As A Probiotic For Nutritional And Medical Applications
  • An Antagonist Specifically Binds To A Denatured Collagens; Antitumor Agents, Antimetastasis Agents; Monoclonal Antibodies; Drug Screening For Denatured Collagen Antagonists
  • Immunising Against Meningococcal Serogroup Y Using Proteins
  • Methods For Treating Brain Cancer Using Il-13r Alpha 2 Peptide-Based Compositions
  • Inducing An Immunological Response In An Animal By Administering To The Animal An Attenuated Csfv Pestivirus, Wherein The Rnase Activity Of Glycoprotein Erns Of The Csfv Pestivirus Is Inactivated By A Deletion Of The Second Histidine Of The Conserved Erns Sequence Rhewnkhgwcnw
  • Neisseria Meningitidis Composition And Methods Thereof
  • Degraded Tpo Agonist Antibody
  • Combination Neisserial Compositions
  • Isolated Gdf Trap Polypeptide
  • Antibodies To Insulin-Like Growth Factor I Receptor
  • Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
  • Methods And Kits For Diagnosis Of Cancer And Prediction Of Therapeutic Value
  • Nucleic Acids And Proteins From Streptococcus Groups A And B
  • Bordetella Vaccines Comprising Lps With Reduced Reactogenicity
  • Ovarian Cancer Cell And Myeloma Cell Surface Glycoproteins, Antibodies Thereto, And Uses Thereof
  • Antibody-Active Agent Conjugates And Methods Of Use
  • Specific Plasmin Inactivation By Anticatalytic Antibody
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Vaccine
  • Protein Signatures For Distinguishing Between Bacterial And Viral Infections
  • Immunising Against Meningococcal Serogroup Y Using Proteins
  • Immune System Modulating Composition
  • Monoclonal Antibodies Against Frizzled
  • Il-21 Ligands
  • Antibody That Binds Cd269 (Bcma) Suitable For Use In The Treatment Of Plasma Cell Diseases Such As Multiple Myeloma And Autoimmune Diseases
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Actriib Proteins And Variants And Uses Therefore Relating To Utrophin Induction For Muscular Dystrophy Therapy
  • Compositions And Methods Relating To A Mutant Clostridium Difficile Toxin
  • Using Mg1(Mucin) Specific Immunoglobulins To Target Therapeutic Agents To Tumor Cells
  • Human Antibodies That Bind Mesothelin, And Uses Thereof
  • Vaccines Against An Oncogenic Isoform Of Her2 (Erbb2) And Methods Of Using The Same
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Adjuvanted Rabies Vaccine With Improved Viscosity Profile
  • Immunogenic Proteins And Compositions
  • Human Antibodies That Bind Mesothelin, And Uses Thereof
  • Methods For Treating Or Preventing Migraine Headache
  • Kit For Detection Of Telomerase Reverse Transcriptase Nucleic Acids
  • Chlamydial Antigens As Reagents For Diagnosis And Treatment Of Chlamydial Infection And Disease
  • Single Expression Vector For Generation Of A Virus With A Segmented Genome
  • Bio-Functionalized Stimulus-Responsive Dissolvable Peg-Hydrogels
  • Antibodies To A Non-Ligand Binding Region Of At Least Two Notch Receptors
  • Methods Of Inhibiting Unwanted Cell Proliferation Using Hedgehog Antagonists
  • Internalizing Human Monoclonal Antibodies Targeting Prostate And Other Cancer Cells
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Sur-Binding Proteins Against Erbb3
  • Her-2 Binding Antagonists
  • High Throughput Cell-Based Hpv Immunoassays For Diagnosis And Screening Of Hpv-Associated Cancers
  • Anti-Glypican-3 Antibody
  • Immunising Against Meningococcal Serogroup Y Using Proteins
  • Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (Pa) Toxin
  • Clostridium Difficile Antibodies
  • Degraded Tpo Agonist Antibody
  • Combination Neisserial Compositions
  • Compositions And Methods Relating To A Mutant Clostridium Difficile Toxin
  • Isolated Gdf Trap Polypeptide
  • Antibodies To Insulin-Like Growth Factor I Receptor
  • Pathogenic Mycobacteria-Derived Mannose-Capped Lipoarabinomannan Antigen Binding Proteins
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Anti-C3d Antibody Conjugates And Methods Of Detecting Complement Activation
  • Antibodies To A Non-Ligand Binding Region Of At Least Two Notch Receptors
  • Methods For Inhibiting Hematopoiesis With A Hedgehog Antagonist
  • Compositions And Methods For The Detection And Treatment Of Methylthioadenosine Phosphorylase Deficient Cancers
  • Hpv Types And Variants Associated With Cervical Cancer And The Uses Thereof
  • Protein Signatures For Distinguishing Between Bacterial And Viral Infections
  • Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
  • Methods And Kits For Diagnosis Of Cancer And Prediction Of Therapeutic Value
  • Immune System Modulating Composition
  • Photosynthetic Microorganisms Expressing Thermostable Lipase
  • Combination Neisserial Compositions
  • Human Anti-Pseudomonas-Aeruginosa It-2 Antibodies Derived From Transgenic Xenomouse
  • Human Monoclonal Antibody Human Cd134 (Ox40) And Methods Of Making And Using Same
  • Immunogens, Compositons And Uses Thereof, Method For Preparing Same
  • Compositions Of, And Methods For, Alpha-1 Anti Trypsin Fc Fusion Molecules
  • Method For Quantitating Total Hmgb1 Protein In Biological Samples
  • Anti-Pseudomonas Psl Binding Molecules And Uses Thereof
  • Method Of Treating Pregnant Cows And/Or Heifers
  • Recombinant Viral-Based Malaria Vaccines
  • Immunogenic Compositions For Gram Positive Bacteria Such As Streptococcus Agalactiae
  • Treatment And Diagnosis Of Cancer
  • Methods Of Inducing An Immune Response
  • Surrogate Binding Proteins Which Bind Dr4 And/Or Dr5
  • Antibodies That Bind Human Cd27 And Uses Thereof
  • Methods Of Treating Neuroendocrine Tumors Using Frizzled-Binding Agents
  • Polynucleotides Encoding Notch1 Receptor Antibodies
  • Notch1 Binding Agents And Methods Of Use Thereof
  • Compositions And Methods Of Enhancing Immune Responses To Eimeria Or Limiting Eimeria Infection
  • Internalizing Human Monoclonal Antibodies Targeting Prostate Cancer Cells In Situ
  • Compositions Comprising Bacterial Strains
  • Pseudomonas Aeruginosa Pcrv Binding Single Variable Domain Antibodies
  • Antibodies Against Clostridium Difficile
  • Anti-C35 Antibody Combination Therapies And Methods
  • Based On A Native Version Of The Enzyme From E. Corrodens And Induces Production Of Antibodies That Inhibit The Activity Of The Lysine Decarboxylase Enzyme In The Oral Cavity; Comprising A Substitution At A Position Corresponding To Position 365 Of Seq Id No:2
  • Serologic Correlates Of Protection Against Bacillus Anthracis Infection
  • Yeast Vaccine Vector Including Immunostimulatory And Antigenic Polypeptides And Methods Of Using The Same
  • Binds To A Denatured Collagens But Not To Native Triple Helical Forms Of The Collagen; Antitumor Agents, Antimetastasis Agents; Monoclonal Antibodies; Drug Screening For Denatured Collagen Antagonists
  • Detection Of Early-Stage Pancreatic Adenocarcinoma
  • Methods For Detecting A Mycobacterium Tuberculosis Infection
  • Vaccine For Treatment Or Prevention Of Burkholderia Infection In A Mammal
  • N-Cadherin: Target For Cancer Diagnosis And Therapy
  • Compounds And Methods For Treatment And Diagnosis Of Chlamydial Infection
  • Methods And Compositions Employing Immunogenic Fusion Proteins
  • Compound And Methods For Diagnosis Of Tuberculosis
  • Recombinant Bacterium To Decrease Tumor Growth
  • Immune System Modulating Composition
  • Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
  • Antibodies Against Clostridium Difficile Toxins And Uses Thereof
  • Targeting Complement Factor H For Treatment Of Diseases
  • Pirin Polypeptide And Immune Modulation
  • Pseudomonas Aeruginosa Pcrv Binding Single Variable Domain Antibodies
  • Binding Moieties For Biofilm Remediation
  • Methods Of Risk Assessment And Disease Classification For Appendicitis
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Method Of Treatment
  • Composition Of Bacteroides Thetaiotaomicron For Immune Modulation
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Anti-Cd37 Immunoconjugate And Anti-Cd20 Antibody Combinations
  • Conserved Neisserial Antigens
  • Antibodies To S. Aureus Surface Determinants
  • Yersinia Pestis Vaccine
  • Compositions Comprising Bacterial Strains
  • Mva Vaccine For Delivery Of A Ul128 Complex And Preventing Cmv Infection
  • Vaccine And Methods To Reduce Campylobacter Infection
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Anti-Cd27 And Anti-Pd-L1 Antibodies And Bispecific Constructs
  • Serologic Correlates Of Protection Against Bacillus Anthracis Infection
  • Staphylococcus Aureus Proteins And Nucleic Acids
  • T24 Antigen For Immunodiagnosis Of Taenia Solium Cysticercosis
  • Consisting Of A Protein Comprising At Least One Epitope Of Human St Receptor Protein Or A Nucleic Acid Molecule That Encodes Protein And A Pharmaceutically Acceptable Carrier Or Diluent
  • Potomac Horse Fever Isolates
  • Angiopoietin-Based Interventions For Treating Cerebral Malaria
  • Methods For Constructing Antibiotic Resistance Free Vaccines
  • Compositions Comprising Bacterial Strains
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Hepatitis C Antibodies And Uses Thereof
  • A Vaccine Containing A Nucleic Acid Expression Vector That Encodes The Catalytic Subunit Of Human Telomerase Reverse Transcriptase (Htrt); Immunostimulants; Anticarcinogenic Agents
  • Complex Of Antigen, Antibodies Or Ligand, Receptors; Therapy, Prevention Of Human Diseases
  • Group A Streptococcus Vaccine
  • Monitoring And Inhibiting Human Immunodeficiency Virus Infection By Modulating Hmgb1 Dependent Triggering Of Hiv-1 Replication And Persistence
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Activin-Actriia Antagonists And Uses For Treating Multiple Myeloma
  • Anti-Ang2 Antibody
  • A Vaccine For Treatment Or Prevention Of Burkholderia Infection In A Mammal
  • Methods Of Treating Pancreatic Or Liver Cancer Using Hedgehog Antagonists
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Bacterial Vaccine Components And Uses Thereof
  • Antibodies To The Notch1 Receptor
  • Mutant Forms Of Streptolysin O
  • Methods For Increasing Thermogenic Adipocytes
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Mva-Gh/Gl-Pc Vaccine Derived Antibodies Neutralizing Human Cytomegalovirus Infectivity And Methods Thereof
  • Attenuated Live Bacteria With Increased Acid Resistance And Methods Of Use Thereof
  • Antibodies That Bind Human Cd27 And Uses Thereof
  • Treatment And Diagnosis Of Cancer
  • Pseudomonas Aeruginosa Pcrv Binding Single Variable Domain Antibodies
  • Yeast Vaccine Vector Including Immunostimulatory And Antigenic Polypeptides And Methods Of Using The Same
  • Composition Of Roseburia Hominis
  • Development Of Masked Therapeutic Antibodies To Limit Off-Target Effects
  • Compositions And Methods Of Enhancing Immune Responses To Eimeria
  • Antibodies Against Cancer Antigen Tmeff2 And Uses Thereof
  • Methods Of Using The Fri Domain Of Human Frizzled Receptor For Inhibiting Wnt Signaling In A Tumor Or Tumor Cell
  • Detection Of Early-Stage Pancreatic Adenocarcinoma
  • Human Monoclonal Antibody Human Cd134 (Ox40) And Methods Of Making And Using Same
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Protective Barrier Compositions And Uses Thereof
  • Met-Binding Agents And Uses Thereof
  • Methods Of Inducing An Immune Response
  • Surrogate Binding Proteins Which Bind Dr4 And/Or Dr5
  • Antibody Fragment Against Folr1
  • Peptide Sequences And Compositions
  • Compositions Of, And Methods For, Alpha-1 Anti Trypsin Fc Fusion Molecules
  • Monitoring And Inhibiting Human Immunodeficiency Virus Infection By Modulating Hmgb1 Dependent Triggering Of Hiv-1 Replication And Persistence
  • Cd37-Binding Molecules And Immunoconjugates Thereof
  • Compositions And Methods Of Enhancing Immune Responses To Enteric Pathogens
  • Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Anti-Pancreatic Cancer Antibodies
  • Compositions Comprising Bacterial Strains
  • Method Of Identifying An Agent That Promotes Bone Growth Or Increases Bone Density
  • Method Of Promoting Bone Growth By An Anti-Activin A Antibody
  • Actriib Proteins And Variants And Uses Therefore Relating To Utrophin Induction For Muscular Dystrophy Therapy
  • Compositions Comprising Bacterial Strains
  • Bacterial Vaccine Components And Uses Thereof
  • Vaccine Vectors And Methods Of Enhancing Immune Responses
  • Mutant Fragments Of Ospa And Methods And Uses Relating Thereto
  • Exposing To Immunogenic Portion Of Protein And/Or Encoding Nucleotide Homologenous To Sequence 20 Or 22b; Eliciting Response To 74p3b3 Protein; Pancreatic Cancer
  • Anti-Pancreatic Cancer Antibodies
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Anti-Mesothelin Antibodies
  • Anti-Mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
  • Novel Nucleic Acid Molecules; Immunospecifically Binding Respiratory Syncytial Virus (Rsv) Antigens; Long Half Life; Reduced Dosage And Side Effects
  • Phosphotriesterase From Agrobacterium Radiobacter P230
  • Staphylococcus Aureus Proteins And Nucleic Acids
  • Enterococcus Faecalis And/Or Enterococcus Faecium Antigen
  • Frizzled-Binding Agents And Uses Thereof
  • Compositions Comprising Bacterial Strains
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Anti-Mpl Antibodies
  • Anti-Arthropod Vector Vaccines, Methods Of Selecting And Uses Thereof
  • Bi-Specific Anti-Cgrp Receptor/Pac1 Receptor Antigen Binding Proteins And Uses Thereof
  • Activin-Actriia Antagonists For Inhibiting Germ Cell Maturation
  • Fusion Comprising A Cell Penetrating Peptide, A Multi Epitope And A Tlr Peptide Agonist For Treatment Of Cancer
  • Using Staphylococcal Protein For Use In Preparing Vaccines And/Or Immunogenic Compositions For Preventing Microorganismal Infection
  • Gna1870-Based Vesicle Vaccines For Broad Spectrum Protection Against Diseases Caused By Neisseria Meningitidis
  • Methods Of Increasing Sarcolemmal Utrophin
  • Cancer Stem Cell Targeted Cancer Vaccines
  • Transgenic Plant Comprising Expression Vector Coding Mannheimia Modified Toxin Protein For Use In Preparing Vaccine Against Respiratory Infection In Domestic Animals; Veterinary Medicine
  • Combining Radioimmunotherapy And Antibody-Drug Conjugates For Improved Cancer Therapy
  • Antibodies To The C3d Fragment Of Complement Component 3
  • Methods And Compositions For Promoting Wound Healing
  • Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
  • Methods And Compositions For Vaccinating Against Staphylococcus Aureus
  • Compositions And Methods For The Removal Of Biofilms
  • Use Of Gdf Traps To Treat Anemia
  • Monoclonal Antibody Which Binds Fetal Thymocytes, Inhibitits Cell Proliferation And Does Not Bind Adult Thymocytes; For Use In Treatment And Prevention Of Cell Proliferative Disorders; Immunotherapy
  • Antibodies Against Human Fzd5 And Fzd8
  • Targeting Of Melanocytes For Delivering Therapeutic Or Diagnostic Agents Using Protein Nanocages
  • Angiopoietin-Based Interventions For Treating Cerebral Malaria
  • Anti-Human Respiratory Syncytial Virus (Rsv) Antibodies And Methods Of Use
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Anti-Mesothelin Antibodies
  • Staphylococcus Aureus Proteins And Nucleic Acids
  • Ehrlichia Canis Diva (Differentiate Infected From Vaccinated Animals)
  • Methods For Increasing Adiponectin In A Patient In Need Thereof
  • Anti-Mesothelin Immunoconjugates And Uses Therefor
  • Proteins With Repetitive Bacterial-Ig-Like (Big) Domains Present In Leptospira Species
  • Methods And Compositions For Chlamydial Antigens For Diagnosis And Treatment Of Chlamydial Infection And Disease
  • Antibodies Against Clostridium Difficile
  • Methods For Detecting A Mycobacterium Tuberculosis Infection
  • Vaccine For Treatment Or Prevention Of Burkholderia Infection In A Mammal
  • Internalizing Human Monoclonal Antibodies Targeting Prostate Cancer Cells In Situ
  • Immunogenic Constructs
  • Methods And Compositions For Promoting Wound Healing
  • Cd37-Binding Molecules And Immunoconjugates Thereof
  • Compounds
  • Compositions Comprising Bacterial Strains
  • Methods For Treating Ulcers In Thalassemia Syndrome With An Actriib Polypeptide
  • Inhibiting Proliferation Of A Antigenmyeloma Tumor Cell Expressing A Ganglioside By Contacting The Cell With An Antibody That Specifically Binds To The Ganglioside; Melanoma, Myeloma, Small Cell Lung Cancer, Thymic Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, Osteosarcoma, And Acute T-Cell Leukemia
  • Anti-Fcrh5 Antibodies And Immunoconjugates And Methods Of Use
  • Compositions Comprising Bacterial Strains
  • Neisseria Meningitidis Composition And Methods Thereof
  • Immunizing Compositions And Methods Of Use
  • Compositions And Methods Related To Protein A (Spa) Variants
  • Cell Death-Inducing Agent
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Amino Acid Sequences Directed Against Human Respiratory Syncytial Virus (Hrsv) And Polypeptides Comprising The Same For The Prevention And/Or Treatment Of Respiratory Tract Infections
  • Method And Composition For Angiogenesis Inhibition
  • Bispecific Anti-Cd37 Antibodies, Monoclonal Anti-Cd37 Antibodies And Methods Of Use Thereof
  • Recombinant Viral-Based Malaria Vaccines
  • Anti-Human Respiratory Syncytial Virus (Rsv) Antibodies And Methods Of Use
  • St2 Antigen Binding Proteins
  • Compositions Useful For The Treatment Of Microbial Infections
  • Isolated Protein And Compositions Comprising The Protein
  • Vaccine Constructs And Uses Thereof Against Staphylococcus Infections
  • Monovalent, Bivalent And Trivalent Anti Human Respiratory Syncytial Virus (Hrsv) Nanobody Constructs For The Prevention And/Or Treatment Of Respiratory Tract Infections
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Human Frizzled (Fzd) Receptor Polypeptides And Methods Of Use Thereof For Treating Cancer And Inhibiting Growth Of Tumor Cells
  • Methods Of Stimulating Protective Immunity Employing Dengue Viral Antigens
  • Compositions Comprising Bacterial Strains
  • Frizzled-Binding Agents And Uses Thereof
  • Therapies For Preventing Or Suppressing Clostridium Difficile Infection
  • Localization And Characterization Of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes And Methods For Their Use
  • Angiopoietin-Based Interventions For Treating Cerebral Malaria
  • Parasite Vaccine
  • Adjuvanted Rabies Vaccine With Improved Viscosity Profile
  • Immunogenic Compositions For Streptococcus Agalactiae
  • Neisseria Meningitidis Composition And Methods Thereof
  • Compositions And Methods Related To Staphylococcal Bacterium Proteins
  • Pseudomonas Aeruginosa Pcrv Binding Single Variable Domain Antibodies
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Compositions Comprising Bacterial Strains
  • Streptococcus Pyogenes Antigens And Corresponding Dna Fragments
  • Mva Vaccine For Delivery Of A Ul128 Complex And Preventing Cmv Infection
  • Methods For Detecting A Mycobacterium Tuberculosis Infection
  • Anti Francisella Tularensis (Ft) Antibodies
  • Anaplasma Phagocytophilum (Aph) Antigens And Antibodies Specific For Anaplasma
  • Mutants Of Cholesterol-Dependent Cytolysins And Uses Thereof
  • Methods And Monitoring Of Treatment With A Wnt Pathway Inhibitor
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Detection Of Early-Stage Pancreatic Adenocarcinoma
  • Chimeric Msp-Based Malaria Vaccine
  • Peptide Vaccine Therapy For Treatment Of Frα-Expressing Tumors
  • Mutated Immunoglobulin-Binding Protein Having Increased Alkaline Tolerance
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Methods And Compositions For Detection Of Ehrlichia Chaffeensis (Vlpt)
  • Psma Antibodies And Uses Thereof
  • Anti-Cd3 Antibodies And Methods Of Use
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Nucleic Acids And Proteins From Streptococcus Groups A And B
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Selectively Targeted Antimicrobial Peptides And The Use Thereof
  • Variants Derived From Actriib
  • Compositions And Methods Relating To A Mutant Clostridium Difficile Toxin
  • Anti-Mesothelin Immunoconjugates And Uses Therefor
  • Antibodies Against Clostridium Difficile Toxins And Uses Thereof
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Neutralizing Anti-Influenza A Antibodies And Uses Thereof
  • Gamma-Glutamyl Transpeptidase Attenuated Francisella
  • Type Iii Secretion System Targeting Molecules
  • Polypeptide And Immune Modulation
  • Rsv-Specific Binding Molecule
  • Compositions Comprising Bacterial Strains
  • Polynucleotides Encoding For Frizzled-Binding Agents And Uses Thereof
  • Neisseria Meningitidis Antigens And Compositions
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Methods For Producing An Immune Response To Tuberculosis
  • Humanized Antibodies Against Cd269 (Bcma)
  • Selectively Targeted Antimicrobial Peptides And The Use Thereof
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Methods And Compositions For Treating Ulcers
  • Administering Primer And Boosting Composition Comprising Source Of One Or More Cd8+ T Cell Epitopes Of Melanoma From A Source Of Non-Replicating Or Replication-Deficient Recombinant Poxvirus Vector In The Human
  • Truncated Actriib-Fc Fusion Protein
  • Compositions Comprising Bacterial Strains
  • Hybridoma Cell Line For Production Of Transmembrane Protein With Egf-Like And 2 Follistatin-Like Domains 2 Specific Immunoglobulin Conjugate For Diagnosis And Treatment Of Prostate Cancer
  • Neisseria Meningitidis Composition And Methods Thereof
  • Methods And Compositions For Immunization Against Chlamydial Infection And Disease
  • Gna1870-Based Vesicle Vaccines For Broad Spectrum Protection Against Diseases Caused By Neisseria Meningitidis
  • Actriia Binding Agents And Uses Thereof
  • Treatment Method For Cockayne Syndrome
  • Stabilised Proteins For Immunising Against Staphylococcus Aureus
  • Glycosylated Specificity Exchangers
  • Chimeric Therapeutic Anti - Cd37 Antibodie Hh1
  • Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells
  • Cancer Vaccines And Methods Of Delivery
  • Recombinant Polyprotein Vaccines For The Treatment And Diagnosis Of Leishmaniasis
  • Stabilizer For Protein Preparation Comprising Meglumine And Use Thereof
  • Vaccines Against An Oncogenic Isoform Of Esr1 And Methods Of Using The Same
  • Wnt Antagonists And Methods Of Treatment And Screening
  • Gas57 Mutant Antigens And Gas57 Antibodies
  • Multiple Variants Of Meningococcal Protein Nbm1870
  • Anti-Human Respiratory Syncytial Virus (Rsv) Antibodies And Methods Of Use
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Anti-Pancreatic Cancer Antibodies
  • Monoclonal Antibody 175 Targeting The Egf Receptor And Derivatives And Uses Thereof
  • Methods Of Modifying P53 Acetylation And Treating Cancer Using Avra
  • Methods And Compositions For Reducing Serum Lipids
  • Monitoring And Inhibiting Human Immunodeficiency Virus Infection By Modulating Hmgb1 Dependent Triggering Of Hiv-1 Replication And Persistence
  • Nucleic Acids And Proteins From Streptococcus Groups A And B
  • Immunogenic Peptides For The Treatment Of Prostate And Breast Cancer
  • Glycosylated Specificity Exchangers
  • Compositions And Methods Of Enhancing Immune Responses To Enteric Pathogens
  • Recombinant Mva Virus
  • Methods And Compositions For Reducing Serum Lipids
  • Nucleic Acids And Proteins From Streptococcus Groups A And B
  • Antibodies Against Cancer Antigen Tmeff2 And Uses Thereof
  • Streptococcus Suis Polypeptides And Polynucleotides Encoding Same And Their Use In Vaccinal And Diagnostic Applications
  • Method Of Treating Cancer By Administering A Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Methods And Compositions For The Treatment And Prevention Of Staphylococcus And Other Bacterial Infections
  • Psma Antibodies And Uses Thereof
  • Immunogenic Peptides For The Treatment Of Prostate And Breast Cancer
  • Glycosylated Specificity Exchangers
  • Compositions Comprising Bacterial Strains
  • Neisseria Meningitidis Composition And Methods Thereof
  • Selectively Targeted Antimicrobial Peptides And The Use Thereof
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Anti-Pancreatic Cancer Antibodies
  • Increasing The Proliferative Capacity Of Cells Using Telomerase Reverse Transcriptase
  • Antibodies Against Clostridium Difficile Toxins And Uses Thereof
  • Proteins Used For The Diagnosis Of Lyme Borreliosis
  • Methods For Detecting A Mycobacterium Tuberculosis Infection
  • Anti Francisella Tularensis (Ft) Antibodies
  • Therapies For Preventing Or Suppressing Clostridium Difficile Infection
  • Anaplasma Phagocytophilum (Aph) Antigens And Antibodies Specific For Anaplasma
  • Mutants Of Cholesterol-Dependent Cytolysins And Uses Thereof
  • Localization And Characterization Of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes And Methods For Their Use
  • Pseudomonas Aeruginosa Pcrv Binding Single Variable Domain Antibodies
  • Anti-Human Respiratory Syncytial Virus (Rsv) Antibodies And Methods Of Use
  • Methods And Monitoring Of Treatment With A Wnt Pathway Inhibitor
  • Compositions Comprising Bacterial Strains
  • Frizzled-Binding Agents And Uses Thereof
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Psma Antibodies And Uses Thereof
  • Treatment Method For Cockayne Syndrome
  • Anti-Cd3 Antibodies And Methods Of Use
  • Actriib-Fc Polynucleotides, Polypeptides, And Compositions
  • Actriia Binding Agents And Uses Thereof
  • Neutralizing Anti-Influenza A Antibodies And Uses Thereof
  • Stabilised Proteins For Immunising Against Staphylococcus Aureus
  • Glycosylated Specificity Exchangers
  • Human Frizzled (Fzd) Receptor Polypeptides And Methods Of Use Thereof For Treating Cancer And Inhibiting Growth Of Tumor Cells
  • Methods Of Stimulating Protective Immunity Employing Dengue Viral Antigens
  • Compositions Comprising Bacterial Strains
  • Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells
  • Chimeric Therapeutic Anti - Cd37 Antibodie Hh1
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Streptococcus Pyogenes Antigens And Corresponding Dna Fragments
  • Acinetobacter Lysins
  • Methods For Treating Ulcers In A Hemoglobinopathy Anemia With A Soluble Actriib Polypeptide
  • Hepatitis C Antibodies And Uses Thereof
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Cytotoxicity-Inducing Theraputic Agent
  • Neisseria Meningitidis Antigens And Compositions
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Novel Method For Treating H.Pylori Infections
  • Anti-Egfr Antibodies And Antibody Drug Conjugates
  • Inhibitors Of Serine Protease Activity And Their Use In Methods And Compositions For Treatment Of Viral Infections
  • Compositions Comprising Bacterial Strains
  • Compositions Comprising Bacterial Strain
  • Immunogenic Compositions For Streptococcus Pyogenes
  • Anti-Mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
  • Lactic Acid Bacterial Strains
  • Human Monoclonal Antibodies Against Bacillus Anthracis Protective Antigen
  • Nucleotide Sequences, Vectors And Host Cells
  • Recombinant Polyprotein Vaccines For The Treatment And Diagnosis Of Leishmaniasis
  • Methods For Treating Or Preventing Migraine Headache
  • Notch1 Receptor Antibodies And Methods Of Treatment
  • Vaccines Against Her3 Antigens And Methods Of Using The Same
  • Fusion Proteins Of Mycobacterium Tuberculosis
  • Sequences Of Brachyspira, Immunogenic Compositions, Methods For Preparation And Use Thereof
  • Methods For Producing An Immune Response To Tuberculosis
  • Monitoring And Inhibiting Human Immunodeficiency Virus Infection By Modulating Hmgb1 Dependent Triggering Of Hiv-1 Replication And Persistence
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/13590

    DOI

    http://dx.doi.org/10.1038/13590

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1043526173

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/10504677


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "author": [
          {
            "affiliation": {
              "alternateName": "Case Western Reserve University, 44106, Cleveland, OH", 
              "id": "http://www.grid.ac/institutes/grid.67105.35", 
              "name": [
                "Case Western Reserve University, 44106, Cleveland, OH"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Greenspan", 
            "givenName": "Neil S.", 
            "id": "sg:person.01104477367.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104477367.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Washington University School of Medicine, 63110, St. Louis, MO", 
              "id": "http://www.grid.ac/institutes/grid.4367.6", 
              "name": [
                "Washington University School of Medicine, 63110, St. Louis, MO"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Di Cera", 
            "givenName": "Enrico", 
            "id": "sg:person.01176762635.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176762635.46"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nbt0297-146", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019182740", 
              "https://doi.org/10.1038/nbt0297-146"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1999-10", 
        "datePublishedReg": "1999-10-01", 
        "genre": "article", 
        "id": "sg:pub.10.1038/13590", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2453819", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2535870", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2629876", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2534370", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1115214", 
            "issn": [
              "1087-0156", 
              "1546-1696"
            ], 
            "name": "Nature Biotechnology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "10", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "17"
          }
        ], 
        "keywords": [
          "epitopes"
        ], 
        "name": "Defining epitopes: It's not as easy as it seems", 
        "pagination": "936-937", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1043526173"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/13590"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "10504677"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/13590", 
          "https://app.dimensions.ai/details/publication/pub.1043526173"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:22", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_330.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/13590"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/13590'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/13590'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/13590'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/13590'


     

    This table displays all metadata directly associated to this object as RDF triples.

    75 TRIPLES      19 PREDICATES      25 URIs      18 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/13590 schema:author N8abd331af09c44479f0150b18f190993
    2 schema:citation sg:pub.10.1038/nbt0297-146
    3 schema:datePublished 1999-10
    4 schema:datePublishedReg 1999-10-01
    5 schema:genre article
    6 schema:isAccessibleForFree false
    7 schema:isPartOf N9b0be6ef0cae4867b9e2633486e2105b
    8 Nace2378f385840c09418f8de96a7acc9
    9 sg:journal.1115214
    10 schema:keywords epitopes
    11 schema:name Defining epitopes: It's not as easy as it seems
    12 schema:pagination 936-937
    13 schema:productId N06fb836da8ae44229b2efe079477f0f8
    14 N677a5c7d272e44c6882b4412f809b88a
    15 Nbb546cec7ad948afb83aa30bee73f910
    16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043526173
    17 https://doi.org/10.1038/13590
    18 schema:sdDatePublished 2022-12-01T06:22
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher N3d853c60346442c9a798b6730a8b7c02
    21 schema:url https://doi.org/10.1038/13590
    22 sgo:license sg:explorer/license/
    23 sgo:sdDataset articles
    24 rdf:type schema:ScholarlyArticle
    25 N06fb836da8ae44229b2efe079477f0f8 schema:name pubmed_id
    26 schema:value 10504677
    27 rdf:type schema:PropertyValue
    28 N3d853c60346442c9a798b6730a8b7c02 schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 N677a5c7d272e44c6882b4412f809b88a schema:name doi
    31 schema:value 10.1038/13590
    32 rdf:type schema:PropertyValue
    33 N8abd331af09c44479f0150b18f190993 rdf:first sg:person.01104477367.10
    34 rdf:rest Ne08e0b5f21714ba481923233171ee585
    35 N9b0be6ef0cae4867b9e2633486e2105b schema:issueNumber 10
    36 rdf:type schema:PublicationIssue
    37 Nace2378f385840c09418f8de96a7acc9 schema:volumeNumber 17
    38 rdf:type schema:PublicationVolume
    39 Nbb546cec7ad948afb83aa30bee73f910 schema:name dimensions_id
    40 schema:value pub.1043526173
    41 rdf:type schema:PropertyValue
    42 Ne08e0b5f21714ba481923233171ee585 rdf:first sg:person.01176762635.46
    43 rdf:rest rdf:nil
    44 sg:grant.2453819 http://pending.schema.org/fundedItem sg:pub.10.1038/13590
    45 rdf:type schema:MonetaryGrant
    46 sg:grant.2534370 http://pending.schema.org/fundedItem sg:pub.10.1038/13590
    47 rdf:type schema:MonetaryGrant
    48 sg:grant.2535870 http://pending.schema.org/fundedItem sg:pub.10.1038/13590
    49 rdf:type schema:MonetaryGrant
    50 sg:grant.2629876 http://pending.schema.org/fundedItem sg:pub.10.1038/13590
    51 rdf:type schema:MonetaryGrant
    52 sg:journal.1115214 schema:issn 1087-0156
    53 1546-1696
    54 schema:name Nature Biotechnology
    55 schema:publisher Springer Nature
    56 rdf:type schema:Periodical
    57 sg:person.01104477367.10 schema:affiliation grid-institutes:grid.67105.35
    58 schema:familyName Greenspan
    59 schema:givenName Neil S.
    60 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104477367.10
    61 rdf:type schema:Person
    62 sg:person.01176762635.46 schema:affiliation grid-institutes:grid.4367.6
    63 schema:familyName Di Cera
    64 schema:givenName Enrico
    65 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176762635.46
    66 rdf:type schema:Person
    67 sg:pub.10.1038/nbt0297-146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019182740
    68 https://doi.org/10.1038/nbt0297-146
    69 rdf:type schema:CreativeWork
    70 grid-institutes:grid.4367.6 schema:alternateName Washington University School of Medicine, 63110, St. Louis, MO
    71 schema:name Washington University School of Medicine, 63110, St. Louis, MO
    72 rdf:type schema:Organization
    73 grid-institutes:grid.67105.35 schema:alternateName Case Western Reserve University, 44106, Cleveland, OH
    74 schema:name Case Western Reserve University, 44106, Cleveland, OH
    75 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...